A Ph. 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety & Efficacy of Evening-dosed HLD200, a Novel Delayed & ER Formulation (DELEXIS) of Methylphenidate Hydrochloride, on Post waking, Early Mor
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Ironshore Pharmaceuticals & Development, Inc
Start Date
December 15, 2015
End Date
December 14, 2016
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Ironshore Pharmaceuticals & Development, Inc
Start Date
December 15, 2015
End Date
December 14, 2016